UC first in U.S. to study Relaxin for heart failure

Medical researchers at the University of Cincinnati are the first in the United States to enroll a patient in a clinical trial to test the effectiveness of the drug Relaxin on treating heart failure symptoms.

UC’s emergency medicine department and division of cardiovascular disease, along with University Hospital’s Center for Emergency Care, will offer patients with symptoms of heart failure the option to enroll in the study.

This approach will allow doctors and researchers to study the effectiveness of the drug from onset to discharge.

Relaxin, produced by Corthera Inc., is a naturally occurring hormone that helps the body regulate kidney function and blood pressure.

Read the full article here.